Molecular epidemiology of imipenem-resistant Acinetobacter haemolyticus and Acinetobacter baumannii isolates carrying plasmid-mediated OXA-40 from a Portuguese hospital [6]

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 9, 2007, Pages 3465-3466

  Quinteira, Sandra ^a   Grosso, Filipa ^b   Ramos, Helena ^c   Peixe, Luísa ^b  

^a Instituto Politécnico de Saúde do Norte   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENOMIC DNA; IMIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; RNA 16S; TICARCILLIN;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER HAEMOLYTICUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BLA OXA 40 GENE; ENDEMIC DISEASE; EPIDEMIC; GENE SEQUENCE; HOSPITAL INFECTION; LETTER; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; PLASMID; PORTUGAL; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION MAPPING;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BACTERIAL PROTEINS; BETA-LACTAMASES; CROSS INFECTION; HUMANS; PLASMIDS; PORTUGAL;

EID: 35948959329     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00267-07     Document Type: Letter

References (13)

1. Afzal-Shah, M., and D. M. Livermore. 1998. Worldwide emergence of carbapenem-resistant Acinetobacter spp. J. Antimicrob. Chemother. 41:576-577.
2. Catchpole, C., J. Andrews, N. Brenwald, and R. Wise. 1997. A reassessment of the in vitro activity of colistin sulphomethate. J. Antimicrob. Chemother. 39:255-260.
3. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; 17th informational supplement, vol. 26. M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Coelho, J., J. Turton, M. Kaufmann, J. Glover, N. Woodford, M. Warner, M. Palepou, R. Pike, T. Pitt, B. Patel, and D. Livermore. 2006. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J. Clin. Microbiol. 44:3623-3627.
5. Da Silva, G., S. Quinteira, E. Bértolo, J. Sousa, L. Gallego, A. Duarte, and L. Peixe. 2004. Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula. J. Antimicrob. Chemother. 54:255-258.
6. Gallego, L., and K. Towner. 2001. Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain. J. Med. Microbiol. 50:71-77.
7. Héritier, C., L. Poirel, D. Aubert, and P. Nordmann. 2003. Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii. Antimicrob. Agents Chemother. 47:268-273.
8. Jones, R., T. Anderegg, and J. Swenson. 2005. Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods. J. Clin. Microbiol. 43:925-927.
9. Lambert, T., G. Gerbaud, M. Galimand, and P. Courvalin. 1993. Characterization of Acinetobacter haemolyticus aac(6′)-Ig gene encoding an aminoglycoside 6′-N-acetyltransferase which modifies amikacin. Antimicrob. Agents Chemother. 37:2093-2100.
10. Lopez-Otsoa, F., L. Gallego, K. Towner, L. Tysall, N. Woodford, and D. Livermore. 2002. Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain. J. Clin. Microbiol. 40:4741-4743.
11. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard M7-A6. National Committee for Clinical Laboratory Standards, Wayne, PA.
12. Poirel, L., and P. Nordmann. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12:826-836.
13. Visalli, M., M. Jacobs, T. Moore, F. Renzi, and P. Appelbaum. 1997. Activities of β-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methods. Antimicrob. Agents Chemother. 41:767-770.